The latest edition of the HPRA newsletter includes important updates to support the safe and appropriate use of the following medicines:
- Chlorhexidine: Inadvertent ocular exposure during surgical site preparation
- Availability of Educational Materials for Valproate (Epilim) and Topiramate (Topamax)
- Product information updates recommended by the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC)
- Direct Healthcare Professional Communications published on the HPRA website since the last Drug Safety Newsletter
- The Importance of Reports of Suspected Adverse Reactions to Pharmacovigilance